在糖尿病前期管理中对Vamana和ShamanaChikitsa进行比较分析:一个随机临床试验
Uttamram Yadav1, Santosh Kumar Bhatted2
1Department of Panchakarma, Vijyashree Ayurveda Medical College & Hospital Jabalpur, India.
Journal of Ayurveda and integrative medicine
|September 22, 2023
概括
阿育吠陀Vamana Karma与草药显著降低了HbA1c在糖尿病前期患者比口服药物更有效. 这项研究强调了Shodhana疗法作为一种更安全,更有效的方法来管理糖尿病前期.
科学领域:
- 综合医学是一个整体的医学.
- 艾尤尔韦达科学 艾尤尔韦达科学
- 代谢健康 代谢健康
背景情况:
- 前糖尿病是糖尿病的前体,与生活方式因素和生化变化有关.
- 传统治疗有局限性;阿育吠陀医学提供了潜在的管理策略.
研究的目的:
- 为了比较Vamana Karma (治疗性吐) 加上Darvyadi Kwatha与口服Darvyadi Kwatha与糖尿病前期个体的生活方式修改的疗效.
- 评估对HbA1c,空腹血葡萄糖 (FBS) 和食后血葡萄糖 (PPBS) 的影响.
主要方法:
- 一项临床试验涉及40名糖尿病前期患者,分为两组.
- 一组接受了Vamana Karma,然后是口服Darvyadi Kwatha;另一组接受了口服Darvyadi Kwatha和生活方式的改变.
- 主要结局包括HbA1c,FBS,PPBS;次要结局评估了消化强度,身体和精神强度,Prameha症状和生活质量 (SF-36).
主要成果:
- 两个治疗组都在初级和二级结局上显示出统计学上显著的改善.
- 在每个组中观察到HbA1c,FBS和PPBS的显著降低 (P < 0.001).
- 对比分析显示,在HbA1c (P < 0.01),FBS (P < 0.01) 和SF-36分数 (P < 0.001) 中,各组之间有显著的改善.
结论:
- 阿育吠陀的Shodhana (净化) 疗法,特别是Vamana Karma,与糖尿病前期的Shamana (缓解) 疗法相比,显示出更高的安全性和有效性.
- 这项研究表明,Vamana Karma之后的草药是糖尿病前期管理的高效治疗方法.
相关概念视频
Diabetes: Management and Pharmacotherapy
302
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
302
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes
971
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
971
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Symptoms, Diagnosis, and Complications
573
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
573
Oral Hypoglycemic Agents: Biguanides and Glitazones
223
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
223


